EU Gears Up For Compulsory Licensing Reform
Executive Summary
The European Commission has laid out a number of possibilities for changing the EU framework on compulsory licensing to improve the availability of products in health emergencies. The options include extending the scope of compulsory licences beyond patents to other forms of protection such as data exclusivity.
You may also be interested in...
EU Sets New Date For Publication Of Delayed Pharma Revision Proposals
Lengthy legislative procedures are expected after the commission publishes its “pharma package” and the “patent package,” which are now due towards the end of April.
EU Sets New Date For Publication Of Delayed Pharma Revision Proposals
Lengthy legislative procedures are expected after the commission publishes its “pharma package” and the “patent package,” which are now due towards the end of April.
EU-Wide Compulsory Licensing Proposal: A Welcome Development Or A Threat To Patent Exclusivity?
As we await the outcome of the public consultation on a possible future EU-level framework for compulsory licensing, Beatriz San Martin and Shishu Chen of law firm Arnold & Porter suggest that if certain “open questions” are addressed satisfactorily, such a framework could allow IP owners to formulate their business strategies more effectively in the event of future health emergencies.